BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35906792)

  • 1. Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study.
    Henze L; Foth S; Meller S; Twele F; Charalambous M; Kenward H; Elliott J; Pelligand L; Volk HA
    J Vet Intern Med; 2022 Sep; 36(5):1726-1732. PubMed ID: 35906792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
    Kenward H; Elliott J; Lee T; Pelligand L
    BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome.
    Foth S; Meller S; Kenward H; Elliott J; Pelligand L; Volk HA
    BMC Vet Res; 2021 Jun; 17(1):222. PubMed ID: 34154584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis.
    Kantyka ME; Meira C; Bettschart-Wolfensberger R; Hartnack S; Kutter APN
    J Vet Emerg Crit Care (San Antonio); 2020 Jul; 30(4):436-441. PubMed ID: 32515910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate.
    Burke JE; Hess RS; Silverstein DC
    J Am Vet Med Assoc; 2021 Dec; 260(S1):S40-S45. PubMed ID: 34914630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT.
    Robson S; McParlin C; Mossop H; Lie M; Fernandez-Garcia C; Howel D; Graham R; Ternent L; Steel A; Goudie N; Nadeem A; Phillipson J; Shehmar M; Simpson N; Tuffnell D; Campbell I; Williams R; O'Hara ME; McColl E; Nelson-Piercy C
    Health Technol Assess; 2021 Nov; 25(63):1-116. PubMed ID: 34782054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.
    Egerton-Warburton D; Meek R; Mee MJ; Braitberg G
    Ann Emerg Med; 2014 Nov; 64(5):526-532.e1. PubMed ID: 24818542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent improvements in antiemetic therapy].
    Roila F; Palladino MA; Ciccarese G; Basurto C
    Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ondansetron with metoclopramide in the symptomatic relief of uremia-induced nausea and vomiting.
    Ljutić D; Perković D; Rumboldt Z; Bagatin J; Hozo I; Pivac N
    Kidney Blood Press Res; 2002; 25(1):61-4. PubMed ID: 11834879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
    Hardy J; Daly S; McQuade B; Albertsson M; Chimontsi-Kypriou V; Stathopoulos P; Curtis P
    Support Care Cancer; 2002 Apr; 10(3):231-6. PubMed ID: 11904788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo.
    Naguib M; el Bakry AK; Khoshim MH; Channa AB; el Gammal M; el Gammal K; Elhattab YS; Attia M; Jaroudi R; Saddique A
    Can J Anaesth; 1996 Mar; 43(3):226-31. PubMed ID: 8829860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice.
    Ithimakin S; Runglodvatana K; Nimmannit A; Akewanlop C; Srimuninnimit V; Keerativitayanan N; Soparattanapaisarn N; Laocharoenkeat A
    Support Care Cancer; 2012 Apr; 20(4):849-55. PubMed ID: 21505898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
    Bonneterre J; Chevallier B; Metz R; Fargeot P; Pujade-Lauraine E; Spielmann M; Tubiana-Hulin M; Paes D; Bons J
    J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting.
    Markham A; Sorkin EM
    Drugs; 1993 Jun; 45(6):931-952. PubMed ID: 7691500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.
    Bhatia A; Tripathi KD; Sharma M
    Indian J Med Res; 2004 Sep; 120(3):183-93. PubMed ID: 15489556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting.
    Polati E; Verlato G; Finco G; Mosaner W; Grosso S; Gottin L; Pinaroli AM; Ischia S
    Anesth Analg; 1997 Aug; 85(2):395-9. PubMed ID: 9249120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis. Ondansetron Delayed Emesis Study Group.
    Olver I; Paska W; Depierre A; Seitz JF; Stewart DJ; Goedhals L; McQuade B; McRae J; Wilkinson JR
    Ann Oncol; 1996 Nov; 7(9):945-52. PubMed ID: 9006746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs.
    Yalcin E; Keser GO
    J Vet Pharmacol Ther; 2017 Dec; 40(6):599-603. PubMed ID: 28198032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International, multicentre, placebo-controlled study to evaluate the effectiveness of ondansetron vs. metoclopramide in the prevention of post-operative nausea and vomiting.
    Morris RW; Aune H; Feiss P; Hanson A; Hasselstrøm L; Maltby JR; Rocke DA; Rozenberg B; Rust M; Cohen LA
    Eur J Anaesthesiol; 1998 Jan; 15(1):69-79. PubMed ID: 9522145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and anti-nausea effects of intravenous ondansetron in hospitalized dogs exhibiting clinical signs of nausea.
    Sotelo CK; Shropshire SB; Quimby J; Simpson S; Gustafson DL; Zersen KM
    J Vet Pharmacol Ther; 2022 Nov; 45(6):508-515. PubMed ID: 35899472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.